openPR Logo
Press release

Plasma Fractionation Market Expected to Hit USD 37.5 Billion by 2032 with a Remarkable 4.28% CAGR

07-15-2025 12:04 PM CET | Health & Medicine

Press release from: Market Research Future (MRFR)

Plasma Fractionation Market

Plasma Fractionation Market

Plasma Fractionation: Unlocking Life-Saving Therapies from Human Blood

Plasma fractionation is a critical process in modern medicine that involves separating and purifying the various components of human plasma to create life-saving therapies. Plasma, the yellowish liquid portion of blood, contains essential proteins such as albumin, immunoglobulins, and clotting factors. These proteins play vital roles in immune defense, blood clotting, and maintaining fluid balance in the body. Through fractionation, these proteins are isolated and transformed into therapeutic products used to treat a wide range of medical conditions.

The Plasma Fractionation Market was valued at USD 22.7 billion in 2023 and is expected to grow steadily over the coming decade. It is projected to reach USD 37.5 billion by 2035, registering a compound annual growth rate (CAGR) of 4.28% from 2025 to 2035. This growth is driven by the rising prevalence of immunodeficiency disorders, increased demand for plasma-derived therapies, and advancements in fractionation technologies. Additionally, expanding healthcare infrastructure and growing awareness about the clinical benefits of plasma products are contributing to the market's positive outlook.

Request To Free Sample of This Strategic Report:https://www.marketresearchfuture.com/sample_request/7397

Key Companies in the Plasma Fractionation Market Include

LFB Group
Takeda Pharmaceutical
Octapharma
Grifols
Popharma
ADMA Biologics
Baxter International
Biotest AG
CSL Behring
Indian Immunologicals
Hualan Biological Engineering
Prothena Corporation
Shire
Kedrion Biopharma

The Science Behind Plasma Fractionation

The process of plasma fractionation is both scientifically complex and highly regulated. It typically begins with the collection of plasma from healthy donors, either through whole blood donation or plasmapheresis, a method that collects only plasma and returns the remaining blood components to the donor.

Once collected, plasma is frozen to preserve the quality of its proteins. The fractionation process involves several steps, including precipitation, chromatography, filtration, and pasteurization. Each step is designed to isolate specific proteins while removing viruses and impurities. For example:

Albumin is extracted for use in treating shock, burns, and liver disease.

Immunoglobulins (IgG) are used to boost the immune system in patients with immunodeficiency disorders.

Clotting factors are essential for managing hemophilia and other bleeding disorders.

You Can Purchase Complete Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=7397

Plasma Fractionation Market Segmentation Insights

Plasma Fractionation Market Application Outlook

Neurology
Hematology
General Medicine
Immunology

Plasma Fractionation Market Product Type Outlook

Immunoglobulin
Albumin
Coagulation Factors
Protease Inhibitors

Plasma Fractionation Market End User Outlook

Hospitals
Ambulatory Surgical Centers
Blood Banks
Pharmaceutical Companies

Plasma Fractionation Market Technology Outlook

Centrifugation
Chromatography
Precipitation
Filtration

Plasma Fractionation Market Regional Outlook

North America
Europe
South America
Asia Pacific
Middle East and Africa

Browse In-depth Market Research Report (Pages, Charts, Tables, Figures): https://www.marketresearchfuture.com/reports/plasma-fractionation-market-7397

Medical Applications and Importance

Plasma-derived therapies are vital for patients with rare, chronic, and life-threatening diseases. They are used to:

Treat primary immune deficiencies by replacing missing antibodies

Control bleeding in individuals with hemophilia

Support patients with autoimmune disorders through immunoglobulin therapy

Stabilize patients undergoing major surgeries or trauma using albumin

Prevent Rh incompatibility in newborns through Rh immunoglobulin

These therapies often have no synthetic substitutes, making plasma fractionation a cornerstone of biopharmaceutical manufacturing.

Safety and Quality Control
Ensuring the safety of plasma-derived products is a top priority. Donor screening, advanced virus inactivation techniques, and strict adherence to Good Manufacturing Practices (GMP) help minimize risks. Technologies such as nanofiltration and solvent-detergent treatment are used to eliminate potential pathogens, making plasma-derived products among the safest biological treatments available.

Global Demand and Supply Challenges
The demand for plasma-based therapies is growing rapidly due to increasing diagnoses of rare diseases, longer life expectancies, and expanding access to healthcare worldwide. However, plasma collection remains a limiting factor. Unlike chemical drugs, plasma-based medicines depend on human donors, and the fractionation process is time-consuming and expensive.

To meet this demand, many countries are investing in awareness campaigns to encourage plasma donation and supporting infrastructure for fractionation plants. Innovation is also playing a role, with advancements in purification technologies and more efficient fractionation methods being developed.

Related Report:

India Aesthetics Market : https://www.marketresearchfuture.com/reports/india-aesthetics-market-45279
South Korea Aesthetics Market : https://www.marketresearchfuture.com/reports/south-korea-aesthetics-market-45282
Uk Aesthetics Market : https://www.marketresearchfuture.com/reports/uk-aesthetics-market-45284
India Ayurvedic Products Market : https://www.marketresearchfuture.com/reports/india-ayurvedic-products-market-45093
Spain Contrast Media Market : https://www.marketresearchfuture.com/reports/spain-contrast-media-market-45269
Us Contrast Media Market : https://www.marketresearchfuture.com/reports/us-contrast-media-market-18710
Us Dravet Syndrome Market : https://www.marketresearchfuture.com/reports/us-dravet-syndrome-market-45219
India Hair Transplant Market : https://www.marketresearchfuture.com/reports/india-hair-transplant-market-45177
Us Hospital Furniture Market : https://www.marketresearchfuture.com/reports/us-hospital-furniture-market-13464
India Knee Replacement Market : https://www.marketresearchfuture.com/reports/india-knee-replacement-market-45125

About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Plasma Fractionation Market Expected to Hit USD 37.5 Billion by 2032 with a Remarkable 4.28% CAGR here

News-ID: 4104506 • Views:

More Releases from Market Research Future (MRFR)

Reinsurance Market to Reach USD 554.14 Billion by 2034, Growing at a 4.7% CAGR | Rising Catastrophic Risks and Capital Requirements Drive Growth
Reinsurance Market to Reach USD 554.14 Billion by 2034, Growing at a 4.7% CAGR | …
The global Reinsurance Market size was estimated at USD 349,393.93 million in 2024 and is projected to grow from USD 365,886.17 million in 2025 to USD 554,142.85 million by 2034, exhibiting a steady CAGR of 4.7% during the forecast period (2025-2034). The market growth is driven by increasing exposure to catastrophic risks, regulatory capital requirements, and the need for risk diversification among primary insurers. Key Market Drivers Rising Catastrophic Events - Increasing frequency
Impact Investing Market to Reach USD 6,046.80 Billion by 2034, Growing at a 14.8% CAGR | ESG Integration and Sustainable Development Goals Drive Growth
Impact Investing Market to Reach USD 6,046.80 Billion by 2034, Growing at a 14.8 …
The global Impact Investing Market size was estimated at USD 1,525.96 billion in 2024 and is projected to grow from USD 1,751.23 billion in 2025 to USD 6,046.80 billion by 2034, exhibiting a robust CAGR of 14.8% during the forecast period (2025-2034). The market growth is driven by the increasing integration of environmental, social, and governance (ESG) criteria in investment decisions, rising global focus on sustainable development goals (SDGs), and growing
Life Insurance Market to Reach USD 110,560.22 Billion by 2034, Growing at a 3.72% CAGR | Rising Health Awareness and Digital Transformation Drive Growth
Life Insurance Market to Reach USD 110,560.22 Billion by 2034, Growing at a 3.72 …
The global Life Insurance Market size was estimated at USD 76,729.73 billion in 2024 and is projected to grow from USD 79,584.26 billion in 2025 to USD 110,560.22 billion by 2034, exhibiting a CAGR of 3.72% during the forecast period (2025-2034). The market growth is driven by rising consumer awareness about financial protection, increasing prevalence of lifestyle-related diseases, digital transformation in insurance services, and supportive regulatory initiatives promoting broader insurance penetration. Key
Private Equity Market to Reach USD 1,290.88 Billion by 2034, Growing at an 8.6% CAGR | Institutional Investments and Tech-Sector Deals Drive Growth
Private Equity Market to Reach USD 1,290.88 Billion by 2034, Growing at an 8.6% …
The global Private Equity Market size was estimated at USD 564.65 billion in 2024 and is projected to grow from USD 613.32 billion in 2025 to USD 1,290.88 billion by 2034, exhibiting a strong CAGR of 8.6% during the forecast period (2025-2034). The market growth is driven by increasing institutional investments, expanding opportunities in emerging markets, and growing interest in technology-driven and ESG-focused private equity deals. Key Market Drivers • Rising Institutional Investments Pension

All 5 Releases


More Releases for Plasma

Blood Plasma Freezers Market Safeguarding Plasma Derivatives: Blood Plasma Freez …
Global Blood Plasma Freezers Market Worth $772.0 Mn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood Plasma Freezers Market- (By Type (Manual Defrost, Automatic Defrost), By Application (Hospital, Laboratory), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Blood Plasma Freezers Market
Contract Plasma Coating Service Market Analysis, Size, Share, Trends, Growth And …
The Global Contract Plasma Coating Service Market report is added by WMR to its database to offer a complete assessment of the factors influencing an overall market growth trend. The research covers significant data and proves to be a handy resource document for industry experts. The research is a perfect balance bridging both qualitative and quantitative information of this market. Quantitative statistics with qualitative reasoning related to market size, share,
Cold Plasma Market Analysis By Top Keyplayers - Plasma Air, Atmospheric plasma t …
The "Cold Plasma Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Cold Plasma Market, 2024-2031 Verified Market Research's most recent report, "Cold Plasma Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination
Contract Plasma Coating Service Market Revenue Sizing Outlook Appears Bright| He …
The Latest research study released by HTF MI "Global Contract Plasma Coating Service Market with 120+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know-how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint, and status. Understanding the segments helps in identifying the importance of different factors that aid market growth. Some of the Major Companies covered in this Research
Contract Plasma Coating Service Market Players Leveraging on Growth Opportunitie …
The Most recent study offered by "Stratagem Market Insights" focuses on Contract Plasma Coating Service Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the market trends in order to assess its current and future potential. Our Market analysis also provides market participants and new entrants with a comprehensive view of
Cold Plasma Market Size, Share - Global Industry Forecast 2032 | Relyon Plasma G …
The market research report offers an in-depth analysis of the Cold Plasma market, helping players to prepare for the increasing hurdles ahead and ensure continued business expansion. With impeccable analysis, exhaustive research, and accurate forecasting, we provide a clear and authoritative study of the global Cold Plasma market, backed by data and figures that have undergone a rigorous verification process. This research is an exhaustive, comprehensive and carefully curated source